Advance Agrolife Q1 FY27 PAT Soars 152% to ₹22.55 Crore on 96% Revenue Growth
Advance Agrolife Limited reported record Q1 FY27 results with revenue at ₹330.4 million, up 96% Y-o-Y. PAT surged 152% to ₹225.5 million. The company is expanding operations with new Unit-4 and Unit-5 manufacturing facilities, expected to enhance production capacity.
The substantial increase in revenue and profit, coupled with aggressive expansion plans for new manufacturing units, indicates a strong positive impact on the company's future growth and market position.
The company reported record-breaking quarterly financial results with significant year-on-year growth in revenue and profit, alongside strategic expansion plans.
Advance Agrolife Limited (AAL), formerly Advance Agrolife Private Limited, has announced its unaudited financial results for the first quarter of the financial year 2026-27, ended on June 30, 2026. The company reported a significant increase in its financial performance, achieving its highest ever quarterly results.
The company's revenue from operations for Q1 FY27 stood at ₹330.4 million (₹33.04 crore), marking a substantial year-on-year (Y-o-Y) increase of 96% and a quarter-on-quarter (Q-o-Q) growth of 167%. This surge in revenue was accompanied by a robust rise in EBITDA, which grew by 105% Y-o-Y and 162% Q-o-Q to ₹35.1 million (₹3.51 crore). The EBITDA margin remained steady at 10.6% for the quarter.
Profit After Tax (PAT) witnessed a remarkable jump of 152% Y-o-Y and 202% Q-o-Q, reaching ₹225.5 million (₹22.55 crore). Diluted Earnings Per Share (EPS) also saw a significant increase of 76% Y-o-Y and 233% Q-o-Q, reaching ₹1.99 per share.
Looking ahead, AAL plans to commence operations at its new Unit-4 technical manufacturing facility in Gidani, Rajasthan, by the third quarter of FY27. Furthermore, the company has initiated the construction of its Unit-5 manufacturing facility in Dahej, Gujarat, which will be dedicated to the production of technical-grade pesticides and is expected to bolster production capacity and support long-term growth.
Commenting on the performance, Mr. Omprakash Choudhary, CMD of Advance Agrolife Limited, highlighted the company's ability to deliver strong results despite global challenges, attributing the success to maintaining adequate inventory and leveraging working capital strengthened by IPO proceeds. He expressed confidence in the company's growth strategy and future prospects.
What to do with a filing like this
Advance Agrolife Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Advance Agrolife Limited. Read the original for the full detail.